Despite being the accepted measure of functional capacity for patients with heart failure (HF), the New York Heart Association (NYHA) classification may be limited in predicting adverse outcomes, especially in mild forms of the condition.
The PARADIGM-HF clinical trial included 8326 patients with known NYHA classification at the time of...
